 | Eli Lilly And Co (LLY) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 23 at 2:27 PM |
 | Should We Worry About Eli Lilly and Company's (NYSE:LLY) P/E Ratio?
finance.yahoo.com - May 22 at 7:05 PM |
| Array BioPharma Gains on Colorectal Cancer Study Success
finance.yahoo.com - May 22 at 7:05 PM |
 | Eli Lilly's Insulin Lispro Injection available at half the list price of Humalog
www.marketwatch.com - May 22 at 8:34 AM |
 | Lilly selling half-price version of popular Humalog insulin
marketbeat.com - May 22 at 6:48 AM |
| Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions
finance.yahoo.com - May 21 at 7:13 PM |
| Why This Biotech Stock Succeeded In Colon Cancer As Others Struggled
finance.yahoo.com - May 21 at 7:13 PM |
 | Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio
www.nasdaq.com - May 20 at 11:41 PM |
 | Top Money Manager Recommends Eli Lilly On Recent Market Dip
www.forbes.com - May 19 at 4:15 PM |
| Better Buy: Eli Lilly vs. Pfizer
finance.yahoo.com - May 19 at 9:07 AM |
| Data Presentations at ASCO 2019 Highlight Lilly's Targeted Approach to Developing Treatments for Patients Living with Cancer
finance.yahoo.com - May 15 at 8:23 PM |
 | Eli Lilly Announces FDA Approval Of CYRAMZA For New Indication
www.finanznachrichten.de - May 13 at 8:35 AM |
| Lilly's CYRAMZA® (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma
finance.yahoo.com - May 13 at 8:35 AM |
 | Two Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpoints
www.prnewswire.com - May 7 at 8:14 PM |
| Insider Selling: Eli Lilly And Co (LLY) SVP Sells 7,577 Shares of Stock
www.americanbankingnews.com - May 7 at 2:33 PM |
| Eli Lilly And Co Plans Quarterly Dividend of $0.65 (LLY)
www.americanbankingnews.com - May 6 at 4:30 PM |
| Lilly Declares Second-Quarter 2019 Dividend
www.prnewswire.com - May 6 at 2:37 PM |
| Edited Transcript of LLY earnings conference call or presentation 30-Apr-19 1:00pm GMT
finance.yahoo.com - May 6 at 8:37 AM |
| AAN 2019: Pooled Analyses of Two Emgality® (galcanezumab-gnlm) Phase 3 Studies Show Reduction in Monthly Migraine Headache Days in Low- and High-Frequency Episodic Migraine Subgroups
finance.yahoo.com - May 6 at 8:37 AM |
| Global Cyclin Dependent Kinase 6 Market 2018- Beta Pharma Inc, Eli Lilly And Company, FLX Bio Inc
www.marketwatch.com - May 4 at 8:43 AM |
| Flippin Bruce & Porter Inc Buys Norfolk Southern Corp, Sells Eli Lilly and Co
finance.yahoo.com - May 3 at 7:03 PM |
| Migraine drugs cause pain for investors
finance.yahoo.com - May 3 at 7:03 PM |
| FY2019 Earnings Forecast for Eli Lilly And Co Issued By Cantor Fitzgerald (LLY)
www.americanbankingnews.com - May 3 at 9:42 AM |
| Global Erectile Dysfunction (ED) Drugs Market to 2023 with Bayer, Eli Lilly and Co, Pfizer, Teva Pharma, & Vivus Dominating
www.prnewswire.com - May 2 at 8:42 AM |
| Lilly to Present New Data at AAN 2019 on Emgality® (galcanezumab-gnlm) and Lasmiditan Reinforcing Breadth of Headache Disorders Portfolio
finance.yahoo.com - May 2 at 8:42 AM |
| Eli Lilly And Co (LLY) Given New $133.00 Price Target at BMO Capital Markets
www.americanbankingnews.com - May 1 at 11:13 AM |
| Eli Lilly misses on revenue in face of pricing pressures and growing generic competition
finance.yahoo.com - May 1 at 8:31 AM |
| Eli Lilly And Co (LLY) Earning Somewhat Favorable Media Coverage, Study Shows
www.americanbankingnews.com - May 1 at 5:52 AM |
 | Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript
www.fool.com - May 1 at 12:10 AM |
| Eli Lilly And Co (LLY) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - April 30 at 9:40 PM |
 | UPDATE 2-Eli Lilly misses estimates for diabetes drug Trulicity, cuts revenue forecast
www.cnbc.com - April 30 at 6:40 PM |
| What's Behind Eli Lilly's Mixed Q1 Results
www.fool.com - April 30 at 6:40 PM |
| Eli Lilly slashes guidance in face of pricing pressures and growing generic competition
www.marketwatch.com - April 30 at 6:40 PM |
| US stock Indicators waver on mixed earnings; Alphabet down
www.americanbankingnews.com - April 30 at 5:04 PM |
| US stock indexes waver on mixed earnings; Alphabet down
marketbeat.com - April 30 at 4:16 PM |
| US stock Indicators Slide on earnings; Alphabet tumbles
www.americanbankingnews.com - April 30 at 3:04 PM |
| US stock indexes slip on mixed earnings; Alphabet tumbles
marketbeat.com - April 30 at 2:25 PM |
| Earnings Results: Eli Lilly slashes guidance in face of pricing pressures and growing generic competition
www.marketwatch.com - April 30 at 11:37 AM |
| Eli Lilly And Co (LLY) Issues Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - April 30 at 11:05 AM |
| Eli Lilly And Co (LLY) Issues FY19 Earnings Guidance
www.americanbankingnews.com - April 30 at 10:22 AM |
| UPDATE 1-Eli Lilly cuts revenue forecast, shares fall
www.cnbc.com - April 30 at 8:32 AM |
| Eli Lilly's stock sinks after earnings beat but revenue comes up short, hurt by Trulicity and Alimta misses
www.marketwatch.com - April 30 at 8:32 AM |
 | Eli Lilly Reports Better-Than-Expected Earnings but Shares Decline
www.thestreet.com - April 30 at 8:32 AM |
| Eli Lilly And Co. Q1 adjusted earnings Beat Estimates
www.finanznachrichten.de - April 30 at 8:32 AM |
| Eli Lilly quarterly profit more than triples on Elanco gain
www.cnbc.com - April 30 at 8:32 AM |
| Eli Lilly misses estimates for diabetes drug Trulicity, cuts revenue forecast
finance.yahoo.com - April 30 at 8:32 AM |
| Eli Lilly And Co (LLY) Updates FY 2019 Earnings Guidance
www.americanbankingnews.com - April 30 at 7:46 AM |
| Earnings Watch: Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Here’s what to expect
www.marketwatch.com - April 29 at 4:47 PM |
| Tomorrow Is Earnings Day for Big Pharma. Here’s What to Watch.
finance.yahoo.com - April 29 at 8:30 AM |
 | Week In Review: Eddingpharm To Pay $375 Million For 2 Lilly Antibiotics And A Suzhou Manufacturing Facility
seekingalpha.com - April 28 at 5:51 PM |
